Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Karyopharm Therapeutics (25K0.F) Q3 2025 Earnings
25K0.F
11
Aug
Confirmed
Q1 2025
Q2 2025
Q3 2025
-3.98
-3.49
-2.99
-2.5
Details
Expected EPS
-3.51394793697
Actual EPS
-3.7191312
Surprise EPS
-0.21
Surprise Percent
+5.84%
Description
Karyopharm Therapeutics (25K0.F) has reported earnings of -3.7191312 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login